Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy

Summary

The purpose of this study is to evaluate the safety and efficacy of dutasteride in reducing drinking and heavy drinking in men and women with alcohol use disorder. The investigators hypothesize that dutasteride 1 mg per day will be well tolerated in this patient population and that, compared to placebo treatment, dutasteride will result in a greater reduction in drinks per week and in the frequency of heavy drinking days.

Timeline

Start

2019-10-15

Primary completion

2024-06-28

Completion

2024-06-28

Drugs

Indications